TLR8 and infection: Yet, the detailed impact of specific hTLR7 or hTLR8 agonists, as well as dual TLR7/8 agonists such as R848 (70), on SARS-CoV-2 infection remains elusive and requires further clinical investigation considering different immune cell types and infection stages.